These studies showed that patients with DLBCL with MYC/BCL2 double-positive (by immunohistochemistry) also have a dismal prognosis, regardless of the status of MYC or BCL2 rearrangement [11, 22, 23]. Here, MYC is linked to diffuse large B-cell lymphoma.